Safety and Preliminary Efficacy of [177Lu]Lu-RTX-2358 Combined With Immune Checkpoint Inhibitors in Patients With FAP-positive Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT07689643 · RECRUITING
Trial details
- NCT number
- NCT07689643
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-28
- Primary completion
- 2027-09-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.